353 related articles for article (PubMed ID: 17007027)
21. Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection.
Dunne PJ; Belaramani L; Fletcher JM; Fernandez de Mattos S; Lawrenz M; Soares MV; Rustin MH; Lam EW; Salmon M; Akbar AN
Blood; 2005 Jul; 106(2):558-65. PubMed ID: 15797994
[TBL] [Abstract][Full Text] [Related]
22. CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion.
Deng Y; Chatterjee B; Zens K; Zdimerova H; Müller A; Schuhmachers P; Ligeon LA; Bongiovanni A; Capaul R; Zbinden A; Holler A; Stauss H; Hammerschmidt W; Münz C
Blood; 2021 Jun; 137(23):3225-3236. PubMed ID: 33827115
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus and disease activity in multiple sclerosis.
Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
[TBL] [Abstract][Full Text] [Related]
24. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
[TBL] [Abstract][Full Text] [Related]
25. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
[TBL] [Abstract][Full Text] [Related]
28. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
[TBL] [Abstract][Full Text] [Related]
29. Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients.
Shoman S; Nabil M; Tabl A; Ghanem H; Kafrawy SE
Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):722-7. PubMed ID: 25317700
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.
Amyes E; Hatton C; Montamat-Sicotte D; Gudgeon N; Rickinson AB; McMichael AJ; Callan MF
J Exp Med; 2003 Sep; 198(6):903-11. PubMed ID: 12975456
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.
Sebelin-Wulf K; Nguyen TD; Oertel S; Papp-Vary M; Trappe RU; Schulzki A; Pezzutto A; Riess H; Subklewe M
Transpl Immunol; 2007 Apr; 17(3):203-10. PubMed ID: 17331848
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: report of two cases.
Gupta E; Bhatia V; Choudhary A; Rastogi A; Gupta NL
J Med Virol; 2013 Mar; 85(3):519-23. PubMed ID: 23297155
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.
Sohlberg E; Saghafian-Hedengren S; Rasul E; Marchini G; Nilsson C; Klein E; Nagy N; Sverremark-Ekström E
J Immunol; 2013 Dec; 191(11):5669-76. PubMed ID: 24140645
[TBL] [Abstract][Full Text] [Related]
36. Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.
Nakid-Cordero C; Arzouk N; Gauthier N; Tarantino N; Larsen M; Choquet S; Burrel S; Autran B; Vieillard V; Guihot A
PLoS One; 2019; 14(10):e0224211. PubMed ID: 31639143
[TBL] [Abstract][Full Text] [Related]
37. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
Abolhassani H; Edwards ES; Ikinciogullari A; Jing H; Borte S; Buggert M; Du L; Matsuda-Lennikov M; Romano R; Caridha R; Bade S; Zhang Y; Frederiksen J; Fang M; Bal SK; Haskologlu S; Dogu F; Tacyildiz N; Matthews HF; McElwee JJ; Gostick E; Price DA; Palendira U; Aghamohammadi A; Boisson B; Rezaei N; Karlsson AC; Lenardo MJ; Casanova JL; Hammarström L; Tangye SG; Su HC; Pan-Hammarström Q
J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864
[TBL] [Abstract][Full Text] [Related]
38. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
Front Immunol; 2018; 9():2291. PubMed ID: 30337929
[TBL] [Abstract][Full Text] [Related]
39. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.
Boutboul F; Puthier D; Appay V; Pellé O; Ait-Mohand H; Combadière B; Carcelain G; Katlama C; Rowland-Jones SL; Debré P; Nguyen C; Autran B
AIDS; 2005 Nov; 19(17):1981-6. PubMed ID: 16260904
[TBL] [Abstract][Full Text] [Related]
40. Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes.
Kimura H; Nagasaka T; Hoshino Y; Hayashi N; Tanaka N; Xu JL; Kuzushima K; Morishima T
Hum Pathol; 2001 Jul; 32(7):757-62. PubMed ID: 11486177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]